Funding for Global Research and Training
The Center for Global Health helps reduce the global burden of cancer by strengthening research capacity through funding and training. Below you will find the most recent funding opportunities that are relevant to our work.
Current Funding Opportunities
Learn more about current international cancer research and cancer control funding opportunities developed by CGH, or supported by NCI in collaboration with other NIH Institutes and Centers or research organizations.
NCI's Cancer Research Training Travel Awards for LMIC Investigators
Link to FOA: https://www.crdfglobal.org/funding-opportunities/ncis-cancer-research-training-travel-awards-lmic-investigators
Application Deadline: October 30, 2020
NCI’s Center for Global Health (CGH), in collaboration with other NCI divisions, supports collaborative research between U.S. investigators and investigators in low- and middle-income countries (LMICs) to expand capacity in performing high-quality cancer research in LMICs. To complement and/or enhance these efforts, CGH, in partnership with CRDF Global, launched the Cancer Research Training Travel Awards for LMIC Investigators. The travel awards are intended to facilitate and increase participation in cancer research training opportunities for LMIC investigators/trainees who seek to conduct high-quality and context–appropriate research in their home institutions.
NIH DS-I Africa Funding Opportunity Announcements
NIH recently issued four NIH funding opportunity announcements published for the Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Common Fund program. The links to each of these opportunities can be found here (and learn more about the program as a whole by following the link above):
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional)
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional)
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Ethical, Legal, and Social Implications Research (U01 Clinical Trial Not Allowed)
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Open Data Science Platform and Coordinating Center (U2C Clinical Trial Not Allowed)
This new program leverages existing data and technologies to develop solutions to the continent’s most pressing clinical and public health problems through a robust ecosystem of new partners from academic, government, and private sectors. The DS-I Africa program will invest $58 million over five years to support data science and innovation research hubs focused on key health problems; data science training programs; research projects that examine ethical, legal and social implications of data science research in Africa; and development of an open data science platform and coordinating center. These funding opportunities are open to African academic and other non-profit organizations in partnership with private sector, government, NGO, and other research partners (from Africa or other parts of the world). The data science training program funding opportunity is also open to U.S. applicants in strong partnership with African institutions.
DS-I Africa Virtual Symposium Platform
The DS-I Africa Virtual Symposium Platform is a collection of networking tools and online events. The Virtual Symposium Platform will be open from July through November 2020 with several online events and networking tools available to participants during that time frame:
• Watch inspiring keynote videos from leaders in health and data science.
• Participate in interactive panel discussions about the funding opportunities, cross-cutting opportunities and challenges in data science, and specific scientific topics.
• Meet and network with potential partners from academia, government, private sector, and NGOs in the DS-I Africa Virtual Forum.
• Request a telephone or video conference consultation with NIH staff
Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)
Funding Announcement: RFA-CA-20-031
The purpose of this Funding Opportunity Announcement is to establish an institutional program for mentored training in global cancer research. This program will support research training led by the U.S.-based cancer research-intensive institutions working in collaboration with institutions in low and middle-income countries (LMICs). The overarching goal of this initiative is to build capacity to conduct innovative and collaborative global research projects that will contribute to the advancement of basic, clinical, translational, and population-based cancer research in LMICs.
Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)
Notice Number: NOT-CA-20-042
The National Cancer Institute is issuing this NOSI to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa. Topics of specific interest to NCI include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer. For more information visit: https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-042.html.
Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
Notice Number: NOT-CA-20-043
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Cancer Institute (NCI) is issuing this NOSI to highlight the urgent need for the development of prophylactic, therapeutic and diagnostic for Coronavirus Disease 2019 (COVID-19). To accelerate the development of promising technologies, the NCI encourages applications from small businesses with NCI-funded active SBIR/STTR awards for technologies that have a strong potential to be adapted/repurposed for use as a prophylactic, therapeutic or diagnostic tool for SARS-CoV-2 (COVID-19). For more information visit: https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-043.html.
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD)
Notice Number: NOT-CA-20-031
The purpose of this Notice is to inform potential applicants of the special interest of the National Cancer Institute in encouraging the submission of applications that advance early detection of head and neck cancer (HNC) by applying genomics, epigenomics, transcriptomics, proteomics, and molecular signatures to clinical studies for differentiating benign lesions from malignant ones. The initiative also encourages novel basic research for HNC cancer prevention as well as the development of molecular markers to combine with current available HNC detection methods for increasing sensitivity and specificity.
Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments
This Notice seeks to inform potential applicants of the interest of the National Cancer Institute (NCI) in supporting implementation research related to cancer prevention and control in low- and middle-income countries (LMICs) and in low-resource settings. NCI encourages applications that pursue innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines in low-resource settings. The research projects on which these applications will be based should be focused on dissemination and implementation research for the primary and secondary prevention of cancer in LMICs and/or in populations facing conditions of vulnerability in high-income countries.
Interested applicants must submit applications for this initiative using one of the following Dissemination and Implementation Research in Health funding opportunity announcements: PAR-19-274 (R01 Clinical Trial Optional); PAR-19-275 (R21 Clinical Trial Optional); PAR-19-276 (R03 Clinical Trial Not Allowed). For more information visit: https://grants.nih.gov/grants/guide/notice-files/NOT-CA-20-025.html.
The purpose of this funding opportunity announcement is to stimulate the development of novel microbial-based cancer therapies, especially for conditions where conventional cancer therapies are inadequate, such as poorly vascularized, hypoxic, solid tumors, dormant or slowly dividing cells resistant to current interventions, and brain tumors. PAR-19-194 (R21 for early stage research); PAR-19-193 (R01 for mature projects). Examples of Applications: (RO1, R21s).
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (Clinical Trial Optional)
These funding opportunities encourage Small Business Innovation Research (SBIR and STTR) grant applications from small business concerns (SBCs) proposing commercially-directed research for the development of cancer prevention, diagnosis, or treatment technologies to improve cancer outcomes in low- and middle-income countries (LMICs), and low-resource settings in the U.S. PAR-18-801 (R43/R44); PAR-18-802 (R41/42). For more information about these funding opportunities, download presentations from the NCI SBIR-CGH Joint Informational Webinar: SBIR-CGH Webinar1; SBIR-CGH Webinar2.
Note: Direct-to-Phase II is allowed for PAR-18-801 https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-003.html.
Dissemination and Implementation Research in Health (Clinical Trial Optional)
This funding opportunity encourages research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices into public health, clinical practice, and community settings. PAR-19-274 (R01); PAR-19-275 (R21).
This funding opportunity encourages research grant applications that will identify, develop, evaluate and refine effective and efficient methods, systems, infrastructures, and strategies to disseminate and implement evidence-based health practices for public health, clinical practice, and community settings.
International Research Scientist Development Award (K01)
This funding opportunity supports intensive, mentored research career development for early stage investigators committed to a cancer research career. PAR-18-539 (Independent clinical trial not allowed). PAR-18-540 (Independent clinical trial required). For additional information, please visit Frequently Asked Questions for the International Research Scientist Development Award.
This funding opportunity supports U.S.- Caribbean collaborative research to develop or extend cohort or surveillance studies on chronic disease in the Caribbean region, aligned with existing, publicly available U.S. datasets.
These funding opportunities highlight research initiatives that align with the efforts of the Cancer Moonshot. Supported with existing or 21st Century Cures Act funds, featured announcements include open funding opportunities.
This funding opportunity supports high quality scientific conferences that are relevant to the NIH's mission and to the public health.
Previously Funded Initiatives
Learn more about CGH’s previously funded research grants and initiatives. Download list of CGH previously funded initiatives.
Learn more about training opportunities available to U.S. and international students, scientists, and health care professionals.
The Short-Term Scientist Exchange Program at the Center for Global Health, National Cancer Institute, promotes collaborative research between researchers at the NCI and foreign cancer researchers.
This program offers two short-term cancer prevention training courses in Rockville, MD to international scientists and healthcare professionals from LMICs and the All-Ireland Cancer Consortium (AICC).